乌梅丸加减治疗稳定性劳力性心绞痛的临床观察  

Clinical observation of stable angina pectoris with the treatment of Wumei Wan

作　　者：谢相智[1] 许国磊[1] 吴欣芳[1] 陈君[1] 

机构地区：[1]中国中医科学院广安门医院南区内一科,北京102600

出　　处：《中国临床药理学与治疗学》2013年第1期83-85,共3页Chinese Journal of Clinical Pharmacology and Therapeutics

摘　　要：目的:观察乌梅丸治疗冠心病稳定性心绞痛患者的临床疗效。方法:采用随机对照的临床试验,将78例稳定型心绞痛患者随机分为治疗组和对照组,治疗4周,通过观察患者临床症状、心电图、西雅图心绞痛量表积分来评定乌梅丸的治疗效果。结果:两组治疗4周后,治疗组在改善患者临床症状和生活质量方面优于对照组,差异有统计学意义(P<0.05),在改善心电图方面差异无统计学意义(P>0.05)。结论:乌梅丸能有效改善冠心病心绞痛患者的临床症状,并能提高患者的生活质量。AIM： To observe the clinical efficacy of treatment of stable angina pectoris with Wumei Wan. METHODS： A randomized con- trolled clinical trial were carried out , 78 patients with stable angina pectoris were randomly divided into Wumei Wan group and control group, patients from Wumei Wan group were treated with Wumei Wan and patients from con- trol group were treated with common treatment. The treatment was lasted for 4 weeks. Clinical efficacy was assessed through the change of clin- ical symptoms, ECG, Seattle Angina scale score. RESULTS. Compared with the control group, after four weeks of treatment, the improving clinical symptoms and quality of life in Wumei Wan group was better, and there was statistically significant difference （P 〈 0.05） there was statistically significant difference in improving ECG （P 〉 0.05）. CONCLUSION： Wumei Wan can effectively improve the clinical symptoms of patients with angina pectoris and improve the patient＇s quality of life.

关 键 词：乌梅丸 稳定性 心绞痛 临床观察 

分 类 号：R541[医药卫生—心血管疾病]